CGTX
Cognition Therapeutics Inc
NASDAQ · Pharmaceuticals
$1.06
+0.06 (+6.03%)
Open$1.00
Previous Close$1.00
Day High$1.08
Day Low$1.00
52W High$36.76
52W Low$16.25
Volume—
Avg Volume529.3K
Market Cap93.57M
P/E Ratio22.03
EPS$1.13
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+2,820.8% upside
Current
$1.06
$1.06
Target
$30.96
$30.96
$22.83
$30.96 avg
$36.58
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 14.30M | 12.78M | 15.45M |
| Net Income | 4.19M | 3.83M | 4.28M |
| Profit Margin | 29.3% | 30.0% | 27.7% |
| EBITDA | 6.72M | 5.55M | 6.77M |
| Free Cash Flow | 3.42M | 2.69M | 4.56M |
| Rev Growth | -4.2% | +12.1% | -7.5% |
| Debt/Equity | 0.88 | 0.74 | 0.77 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |